Similarly, high protein tyrosine kinase 7 (PTK7) expression has been associated with improved disease-free survival in breast cancer patients receiving taxane-based chemotherapy, but with worse disease-free survival in breast cancer or acute myeloid leukemia patients receiving anthracycline chemotherapy [34, 35]. This evidence concerns the gene PTK7 and acute myeloid leukemia.